Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 3Phase 1 2Phase 4 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tumor Response Rate 1Hepatic Malignancies 1Carcinoma, Hepatocellular 1

Interventions

Exercise 440Blood Specimen Collection 334Standard of Care 325Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 246Radiosurgery 245Methods 231Educational Status 231Early Intervention, Educational 219Interviews as Topic 149Practice Guidelines as Topic 147Biopsy 145Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 111Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 96Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 82Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Interventional × Sirtuins × Clear all
NCT05994859 2023-09-14

SIRT for Potentially Resectable HCC

Second Affiliated Hospital of Guangzhou Medical University

Phase NA Recruiting
35 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04332419 2022-06-22

Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

Case Comprehensive Cancer Center

Phase NA Completed
11 enrolled 7 charts

Hepatic Malignancies

NCT03910140 2019-04-10

TILA-TACE in Treatment of Hepatocellular Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Unknown
2,000 enrolled

Tumor Response Rate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡